Healthcare -
Biotechnology - NASDAQ - US
$ 129.12
1.24 %
$ 6.3 B
Market Cap
-21.52
P/E
AXSM - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AXSM - Axsome Therapeutics, Inc.
57.8 M
LAST VALUE
-54.92%
2 YEAR CAGR
-25.52%
5 YEAR CAGR
27.42%
10 YEAR CAGR